Serotonergic drugs : effects on appetite expression and use for the treatment of obesity (Q28282364)

Europe PubMed Central

title

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity (English)

0 references

0 references

1 reference

5

John E Blundell

0 references

Clare Lawton

4

object named as

Clare L Lawton

0 references

Emma Boyland

object named as

Emma J Boyland

3

0 references

author name string

Jason C G Halford

1

0 references

Joanne A Harrold

Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors

2

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

Drugs

0 references

volume

67

0 references

issue

1

0 references

page(s)

27-55

0 references

cites work

1 reference

12 December 2020

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

12 December 2020

Individual severity of dietary obesity in unselected Wistar rats: relationship with hyperphagia

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Studies on food intake of genetically obese rats

1 reference

12 December 2020

Changes in responsiveness to serotonin on rat ventromedial hypothalamic neurons after food deprivation

1 reference

12 December 2020

Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects

1 reference

12 December 2020

5-HT1A receptor immunoreactivity in hypothalamic neurons involved in body weight control

1 reference

12 December 2020

Inhibition of drug-induced anorexia in rats by methysergide

1 reference

12 December 2020

Sumatriptan decreases food intake and increases plasma growth hormone in healthy women.

1 reference

12 December 2020

1 reference

12 December 2020

Clinical studies with fluoxetine in obesity

1 reference

12 December 2020

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

1 reference

12 December 2020

Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release

1 reference

12 December 2020

Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake.

1 reference

12 December 2020

Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test

1 reference

12 December 2020

The effects of dieting on plasma tryptophan concentration and food intake in healthy women

1 reference

12 December 2020

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Dysregulation of hypothalamic serotonin turnover in diet-induced obese rats

1 reference

12 December 2020

Effect of nutritional status and ozone exposure on rat brain serotonin

1 reference

12 December 2020

Opposite changes in striatal neuropeptide Y immunoreactivity after partial and complete serotonergic depletion in the rat.

1 reference

12 December 2020

Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat.

1 reference

12 December 2020

The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects

1 reference

12 December 2020

Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia

1 reference

12 December 2020

Involvement of the serotonergic system in orexin-induced behavioral alterations in rats

1 reference

12 December 2020

Serotonin receptor ligands and the treatment of obesity

1 reference

12 December 2020

Potential strategies for ameliorating early cancer anorexia

1 reference

12 December 2020

Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents

1 reference

12 December 2020

Twenty-four–hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction

1 reference

12 December 2020

Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome

1 reference

12 December 2020

Experimental Studies on Changes of Neuroendocrine Functions during Starvation and Refeeding

1 reference

12 December 2020

Sibutramine reduces food intake in non-dieting women with obesity

1 reference

12 December 2020

5-HT 2C receptor activation decreases appetite and body weight in obese subjects

1 reference

12 December 2020

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

1 reference

12 December 2020

Is there a role for serotonin (5-hydroxytryptamine) in feeding?

1 reference

12 December 2020

Central serotonin and melanocortin pathways regulating energy homeostasis

1 reference

12 December 2020

Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A/B agonist, eltoprazine, on the behavioural satiety sequence

1 reference

12 December 2020

Thermogenic effects of sibutramine in humans

1 reference

12 December 2020

Distribution of orexin neurons in the adult rat brain

1 reference

12 December 2020

Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice

1 reference

12 December 2020

Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients

1 reference

12 December 2020

The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks

1 reference

12 December 2020

Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.

1 reference

12 December 2020

Separate systems for serotonin and leptin in appetite control

1 reference

12 December 2020

Fluoxetine's effect on weight loss in obese subjects

1 reference

12 December 2020

Fluoxetine: a randomized clinical trial in the treatment of obesity

1 reference

12 December 2020

The clinical pharmacology of appetite suppressant drugs

1 reference

12 December 2020

Orexins and feeding: special occasions or everyday occurrence?

1 reference

12 December 2020

Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats

1 reference

12 December 2020

An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats

1 reference

12 December 2020

Effect of fenfluramine on food intake, mood, and performance of humans living in a residential laboratory

1 reference

12 December 2020

Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists

1 reference

12 December 2020

Dopamine and serotonin VMN release is related to feeding status in obese and lean Zucker rats

1 reference

12 December 2020

Moderate dieting causes 5-HT2C receptor supersensitivity.

1 reference

12 December 2020

Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.

1 reference

12 December 2020

Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success

1 reference

12 December 2020

d-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects

1 reference

12 December 2020

Levels of hypothalamic neurotransmitters in lean and obese Zucker rats

1 reference

12 December 2020

Hyperphagia following intraventricular p-chlorophenylalanine-, leucine- or tryptophan-methyl esters: Lack of correlation with whole brain serotonin levels

1 reference

12 December 2020

Clinical studies with d-fenfluramine

1 reference

12 December 2020

Sertraline, a serotonin-uptake inhibitor, reduces food intake and body weight in lean rats and genetically obese mice

1 reference

12 December 2020

Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity

1 reference

12 December 2020

CP-94, 253: a selective serotonin1B (5-HT1B) agonist that promotes satiety

1 reference

12 December 2020

Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord

1 reference

12 December 2020

Differential expression of orexin receptors 1 and 2 in the rat brain

1 reference

12 December 2020

Reduction of feeding behavior by the serotonin uptake inhibitor sertraline

1 reference

12 December 2020

Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes

1 reference

12 December 2020

Interleukin-1alpha injection into ventromedial hypothalamic nucleus of normal rats depresses food intake and increases release of dopamine and serotonin

1 reference

12 December 2020

Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline).

1 reference

12 December 2020

Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline

1 reference

12 December 2020

Fluoxetine-maintained obese humans: effect on food intake and body weight

1 reference

12 December 2020

Cancer anorexia: new pathogenic and therapeutic insights

1 reference

12 December 2020

Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.

1 reference

12 December 2020

Chronic paroxetine infusion influences macronutrient selection in male Sprague-Dawley rats

1 reference

12 December 2020

A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin

1 reference

12 December 2020

Modalities of the food intake-reducing effect of sibutramine in humans

1 reference

12 December 2020

An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats

1 reference

12 December 2020

Integration of hypothalamic feeding and metabolic signals: focus on neuropeptide Y.

1 reference

12 December 2020

International trial of long-term dexfenfluramine in obesity.

1 reference

12 December 2020

Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine

1 reference

12 December 2020

Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification

1 reference

12 December 2020

Ineffectiveness of hypothalamic serotonin to block neuropeptide Y-induced feeding

1 reference

12 December 2020

Obesity drugs in clinical development.

1 reference

12 December 2020

Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial

1 reference

12 December 2020

Drug therapy after very-low-calorie diets

1 reference

12 December 2020

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

1 reference

12 December 2020

Parabrachial infusion of D-fenfluramine reduces food intake. Blockade by the 5-HT(1B) antagonist SB-216641.

1 reference

12 December 2020

Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice

1 reference

12 December 2020

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

12 December 2020

Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity

1 reference

12 December 2020

Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat

1 reference

12 December 2020

Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan

1 reference

12 December 2020

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin

1 reference

12 December 2020

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

1 reference

12 December 2020

On the mechanism of action of dexfenfluramine: effect on alliesthesia and appetite motivation in lean and obese subjects

1 reference

12 December 2020

Indoline derivatives as 5-HT(2C) receptor agonists.

1 reference

12 December 2020

Differential effect of d-fenfluramine and metergoline on food intake in human subjects

1 reference

12 December 2020

Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors

1 reference

12 December 2020

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

12 December 2020

d-fenfluramine in a rat model of dietary fat-induced obesity

1 reference

12 December 2020

The efficacy and safety of sibutramine for weight loss: a systematic review

1 reference

12 December 2020

Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges

1 reference

12 December 2020

Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence.

1 reference

12 December 2020

Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline.

1 reference

12 December 2020

Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists

1 reference

12 December 2020

Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation

1 reference

12 December 2020

Activation of central melanocortin pathways by fenfluramine

1 reference

12 December 2020

Effect of zimelidine, a new antidepressant, on appetite and body weight

1 reference

12 December 2020

Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.

1 reference

12 December 2020

Anti-obesity drug development

1 reference

12 December 2020

Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects.

1 reference

12 December 2020

Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.

1 reference

12 December 2020

A behavioural profile of fluoxetine-induced anorexia

1 reference

12 December 2020

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

1 reference

12 December 2020

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

1 reference

12 December 2020

Serotonergic control of the organization of feeding and satiety

1 reference

12 December 2020

Current and investigational antiobesity agents and obesity therapeutic treatment targets

1 reference

12 December 2020

m-Chlorophenylpiperazine decreases food intake in a test meal

1 reference

12 December 2020

Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake

1 reference

12 December 2020

Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity

1 reference

12 December 2020

5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome

1 reference

12 December 2020

Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine

1 reference

12 December 2020

Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats

1 reference

12 December 2020

5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253

1 reference

12 December 2020

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

1 reference

12 December 2020

1 reference

12 December 2020

The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence

1 reference

12 December 2020

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone

1 reference

12 December 2020